Welcome to our dedicated page for Earth Science Te news (Ticker: ETST), a resource for investors and traders seeking the latest updates and insights on Earth Science Te stock.
Earth Science Tech, Inc. reports news on its role as a diversified healthcare and wellness holding company with OTC-traded common stock. Recurring updates cover its compounding pharmacy operations, including RxCompoundStore.com and Mister Meds, and telemedicine platforms such as Peaks Curative, DOConsultation, MOCTeledoc and MyOnlineConsultation.com.
Company announcements also address financial results, public-company governance, auditor and investor-relations changes, industry-classification updates, FINRA quotation clearance, and portfolio activity outside healthcare through Avenvi real estate and asset management and MagneChef direct-to-consumer products.
Earth Science Tech (OTC: ETST) announced plans to release its second-quarter fiscal results for 2023, ending September 30, 2022, on November 14, 2022, at 4:00 PM ET. Following this, a conference call will be held at 5:00 PM ET to discuss the results and business outlook. The company focuses on acquiring health and wellness firms through its subsidiaries, RxCompoundStore.com and Peaks Curative. Notably, RxCompound is set to launch a sterile compounding room in January 2023, while Peaks is finalizing its website upgrade for a full launch planned for January 2023.
Earth Science Tech, Inc. (ETST) will announce its financial results for the second quarter of fiscal 2023, ending September 30, 2022, on November 14, 2022, at 4:00 PM ET. Following this, a conference call will be held at 5:00 PM ET to discuss the results, including highlights and future outlook. The Company is in a pending transaction to enter compounding pharmaceuticals and telemedicine, which indicates a strategic shift towards expanding its healthcare services.
Earth Science Tech, Inc. (OTC: ETST) announces the Phase I acquisition of RxCompoundstore.com, LLC. and Peaks Curative, LLC. as part of a new strategic direction. Both entities are now wholly owned subsidiaries, enhancing ETST's expansion efforts. RxCS's operations will be led by Mario Tabraue, who plans to launch Peaks Curative's website and product line soon. The acquisition aims to increase revenue through compounding injectables and a marketing strategy involving influencers. Phase II acquisition is expected in 2022, potentially leading to a name and ticker change.
Earth Science Tech, Inc. (OTC: ETST) has announced a dual-phase acquisition strategy involving RxCompoundstore.com, Peaks Curative, and JCR Medical Equipment to enhance its market positioning in the pharmaceutical compounding, telemedicine, and medical equipment sectors. Phase I, set to start in October 2021, includes RxCS and PC, targeting a collective market worth over $73 billion with a CAGR of 11.5%. Phase II will involve JCR, aiming for a market estimated at $1 billion with a CAGR of 6.4%. The acquisitions aim to maximize shareholder value and integrate operations efficiently.
Earth Science Tech, Inc. (OTC: ETST) has regained its current status with the SEC, filing delinquent reports for both the year-end and quarterly periods. This recovery was facilitated by new receiver William A. Leonard, who replaced former receiver Robert L. Stevens amidst shareholder litigation. The company is also pursuing acquisitions, including JCR Medical Equipment, enhancing its operational capacity with new office space. Additionally, ETST is in talks to license its medical device, HygeeTM, while continuing to sell remaining inventory of hemp products.